| Document Date: 2012-11-27 15:44:54
Open Document File Size: 74,09 KBShare Result on Facebook
City Temsirolimus / Cancer Care / / Company Care / Genitourinary Cancer Disease Site Group / / / Facility Memorial Sloan-Kettering Cancer Center / / / IndustryTerm therapy for patients with poor-risk disease / Cancer Care / / MedicalCondition hypertension / disease / primary tumours / shortness of breath / intermediate-risk2 disease / neutropenia / tumour / stomatitis / thrombocytopenia / intermediaterisk2 disease / fever / vomiting / diarrhea / cough / infections / pneumonitis / poor-risk disease / rash / anemia / syndrome / Metastatic Renal Cell Cancer / / MedicalTreatment radiotherapy / immunotherapy / experimental therapy / / Organization Memorial Sloan-Kettering Cancer Center / Ministry of Health / / Person Sebastien Hotte / Eric Winquist / Genitourinary Cancer / / / Position Co-Chair / Chair / / ProvinceOrState Ontario / / Technology alpha / / URL http /
SocialTag |
EVIDENCE-BASED SERIES #[removed]Evidence-Based Series #3-8-4: Section 1 The Use of Inhibitors of Angiogenesis in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: